Obesity Correlation with Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer

Obesity Correlation with Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer

Show other versions (1)

Study Objectives To compare breast cancer metastases between obese and nonobese women and to evaluate the effect of first-line metastatic chemotherapy in each group. Method A retrospective study was performed in an educational institute in Ireland. The study consisted of two parts: the first part wa...

Full description

Bibliographic Details
Main Authors:	Mohammed A. Osman, Bryan T. Hennessy
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-01-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	https://doi.org/10.4137/CMO.S32812

Similar Items

Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer
by: Mohammed A. Osman, et al.
Published: (2015-11-01)

Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review
by: Alessandra Gennari, et al.
Published: (2011-09-01)

Biomarkers for evaluating response to chemotherapy in metastatic breast cancer patients
by: Nidhal A.K. Mohammed Ali, et al.
Published: (2017-07-01)

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
by: Valentina Giannini, et al.
Published: (2022-01-01)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer
by: Yan Song, et al.
Published: (2015-01-01)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2- Metastatic Breast Cancer
by: Yan Song, et al.
Published: (2015-09-01)

First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study
by: Meryem Aitelhaj, et al.
Published: (2016-08-01)

PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST - LINE CHEMOTHERAPY
by: Deyan Davidov
Published: (2017-05-01)

Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
by: S Whyte, et al.
Published: (2010-10-01)

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial
by: Liu MC, et al.
Published: (2019-12-01)

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
by: Shun Yamamoto, et al.
Published: (2021-10-01)

Metastatic Urothelial Tumor Progression Following First Line Chemotherapy: Prognostic Factors and Importance of Second Line Chemotherapy
by: Mohammad S. Ma’koseh, et al.
Published: (2018-07-01)

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
by: Tassinari E, et al.
Published: (2022-06-01)

Chemotherapy options for metastatic colorectal carcinoma: First, second, third line...
by: Tomašević Zorica I., et al.
Published: (2003-01-01)

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer
by: Zhengda Pei, et al.
Published: (2023-10-01)

Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer
by: Fisch MJ, et al.
Published: (2020-03-01)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
by: Maltoni Roberta, et al.
Published: (2006-03-01)

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
by: Amélie Darlix, et al.
Published: (2019-01-01)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
by: Hwang Jun-Eul, et al.
Published: (2011-11-01)

Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer
by: Ying-tao Lin, et al.
Published: (2024-01-01)

Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
by: Stephen Dyar, et al.
Published: (2011-01-01)

Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
by: Stephen Dyar, et al.
Published: (2011-11-01)

ROLE OF PERIOPERATIVE CHEMOTHERAPY IN COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER WITH ISOLATED LUNG OR LIVER METASTASES
by: L. V. Bolotina, et al.
Published: (2015-02-01)

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
by: Boulaamane Lamiaa, et al.
Published: (2012-03-01)

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program
by: Luc Cabel, et al.
Published: (2021-04-01)

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
by: Adams, R, et al.
Published: (2008)

Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
by: Sami Antoun, et al.
Published: (2019-08-01)

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
by: Marta Schirripa, et al.
Published: (2018-01-01)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
by: Susanne Klein-Scory, et al.
Published: (2020-07-01)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report
by: Nikolai A. Ognerubov, et al.
Published: (2021-08-01)

Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma
by: Guo‐Ying Liu, et al.
Published: (2020-02-01)

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report
by: Roberta Marciano, et al.
Published: (2017-09-01)

Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study
by: Caterina Vivaldi, et al.
Published: (2019-07-01)

Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
by: Yogesh Vashist, et al.
Published: (2022-07-01)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
by: Renaud Sabatier, et al.
Published: (2021-03-01)

Sequential Metastatic Breast Cancer Chemotherapy:Should the Median be the Message?
by: Su Yon eJung, et al.
Published: (2013-11-01)

Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel
by: Filippo Montemurro
Published: (2010-09-01)

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
by: Sharman Moser S, et al.
Published: (2024-03-01)

Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer
by: Yang Yuan, et al.
Published: (2023-06-01)